Control | Pre-post p-value | Exercise | Pre-post p-value | Δ-change p-value | |||
---|---|---|---|---|---|---|---|
Pre (0 weeks) | Post (20 weeks) | Pre (0 weeks) | Post (20 weeks) | ||||
n = 25 | n = 24 | n = 24 | n = 24 | ||||
VO2 max (mlO2/min/kg) | 17.2 (15.2–19.9) | 16 (14.8–19-7) | 0.45 | 19.3 (17.6–21.3) | 21.5 (19.2–24.2) | < 0.0001 | < 0.0001 |
STS (number) | 21 (19–26) | 24 (20–28) | 0.02 | 23 (21–25) | 27 (25–28) | < 0.0001 | 0.02 |
HAQ-DI | 0.50 (0.25–0.94) | 0.50 (0.25–0.97) | 0.69 | 0.19 (0.0–0.84) | 0.13 (0.0–0.72) | 0.61 | 0.81 |
BMI | 27.5 (24.8–30.4) | 27.6 (24.6–29.8) | 0.63 | 25.5 (21.4–28.0) | 24.9 (21.3–27.9) | 0.005 | 0.053 |
Systolic BP (mm Hg) | 130 (123–145) | 128 (120–134) | 0.24 | 133 (130–140) | 130 (120–134) | 0.004 | 0.43 |
Diastolic BP (mm Hg) | 80 (75–80) | 80 (75–80) | 0.92 | 80 (76–80) | 80 (70–84) | 0.51 | 0.77 |
CRP | 2 (1–4) | 2 (1–4) | 0.65 | 2.5 (1–5.75) | 2 (1–5.75) | 0.36 | 0.73 |
N/L ratio | 1.79 (1.31–2.76) | 2.09 (1.29–2.78) | 0.88 | 2.11 (1.53–2.96) | 2.03 (1.38–2.75) | 0.80 | 0.56 |
DAS28 | 2.27 (1.56–3.26) | 2.12 (1.62–2.73) | 0.63 | 2.23 (1.24–3.22) | 2.04 (1.50–2.79) | 0.47 | 0.88 |
CDAI | 3.9 (2.6–6.6)) | 3.8 (2.0–6.9) | 0.30 | 3.2 (2.0–7.1) | 2.2 (0.7–8.0) | 0.09 | 0.31 |
PGIC | – | 3 (2.3–3.8) | – | 2 (2.0–3.0) | 0.02 |